SynthesisClinical cancer research : an official journal of the American Association for Cancer Research2026

Zanidatamab, a Dual HER2-Targeted Bispecific Antibody, in Patients with Unresectable Locally Advanced or Metastatic HER2-Positive Salivary Gland Cancer: A Combined Analysis of Early-Phase Studies.

Keun-Wook Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.